Terms: = Pancreatic cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Diagnosis
112 results:
1. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma.
Debernardi S; Liszka L; Ntala C; Steiger K; Esposito I; Carlotti E; Baker AM; McDonald S; Graham T; Dmitrovic B; Feakins RM; Crnogorac-Jurcevic T
Mol Oncol; 2024 Mar; 18(3):677-690. PubMed ID: 38145461
[TBL] [Abstract] [Full Text] [Related]
2. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
[TBL] [Abstract] [Full Text] [Related]
3. Mutation Analysis of pancreatic Juice and Plasma for the Detection of pancreatic cancer.
Levink IJM; Jansen MPHM; Azmani Z; van IJcken W; van Marion R; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685923
[TBL] [Abstract] [Full Text] [Related]
4. Current status of molecular diagnostic approaches using liquid biopsy.
Takahashi K; Takeda Y; Ono Y; Isomoto H; Mizukami Y
J Gastroenterol; 2023 Sep; 58(9):834-847. PubMed ID: 37470859
[TBL] [Abstract] [Full Text] [Related]
5. Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients.
Wang Y; Ge W; Xue S; Cui J; Zhang X; Mao T; Xu H; Li S; Ma J; Yue M; Shentu D; Wang L
IET Syst Biol; 2023 Aug; 17(4):174-186. PubMed ID: 37341253
[TBL] [Abstract] [Full Text] [Related]
6. Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis.
Pflüger MJ; Jamouss KT; Afghani E; Lim SJ; Rodriguez Franco S; Mayo H; Spann M; Wang H; Singhi A; Lennon AM; Wood LD
Pancreatology; 2023 Nov; 23(7):868-877. PubMed ID: 37230894
[TBL] [Abstract] [Full Text] [Related]
7. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in pancreatic Ductal Adenocarcinoma: A Retrospective Analysis.
Masuda S; Yamakawa K; Masuda A; Toyama H; Sofue K; Nanno Y; Komatsu S; Omiya S; Sakai A; Kobayashi T; Tanaka T; Tsujimae M; Ashina S; Gonda M; Abe S; Uemura H; Kohashi S; Inomata N; Nagao K; Harada Y; Miki M; Irie Y; Juri N; Kanzawa M; Itoh T; Fukumoto T; Kodama Y
Ann Surg Oncol; 2023 Sep; 30(9):5776-5787. PubMed ID: 37191859
[TBL] [Abstract] [Full Text] [Related]
8. Establishment and Molecular Characterization of Two Patient-Derived pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response.
Braun R; Lapshyna O; Watzelt J; Drenckhan M; Künstner A; Färber B; Hael AAM; Bolm L; Honselmann KC; Konukiewitz B; Castven D; Spielmann M; Gorantla SP; Busch H; Marquardt JU; Keck T; Wellner UF; Ungefroren H
Cells; 2023 Feb; 12(4):. PubMed ID: 36831254
[TBL] [Abstract] [Full Text] [Related]
9. Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities.
Wang T; Askan G; Ozcan K; Rana S; Zehir A; Bhanot UK; Yantiss RK; Rao DS; Wahl SJ; Bagci P; Balci S; Balachandran V; Jarnagin WR; Adsay NV; Klimstra DS; Basturk O
Arch Pathol Lab Med; 2023 Dec; 147(12):1390-1401. PubMed ID: 36821179
[TBL] [Abstract] [Full Text] [Related]
10. Integrated Genomic and Clinicopathologic Approach Distinguishes pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
[TBL] [Abstract] [Full Text] [Related]
11. Modern aspects of the management of pancreatic intraductal papillary mucinous neoplasms: a narrative review.
Pavlidis ET; Sapalidis KG; Pavlidis TE
Rom J Morphol Embryol; 2022; 63(3):491-502. PubMed ID: 36588487
[TBL] [Abstract] [Full Text] [Related]
12. Adult Pancreatoblastoma: Report of 3 new Cases With Genetic Diversity and Autopsy Findings.
Machado I; López-Guerrero JA; Fernandez A; López R; García Casado Z; Ferrandez A; Llombart-Bosch A; Charville GW
Int J Surg Pathol; 2023 Aug; 31(5):896-906. PubMed ID: 36573045
[TBL] [Abstract] [Full Text] [Related]
13. Pancreatoblastoma in Elderly Adults: Report of Two Patients.
Kulak O; Osipov A; Hendifar AE; Nissen NN; Cox BK; Hruban RH; Hutchings DA
Int J Surg Pathol; 2023 Aug; 31(5):772-777. PubMed ID: 36314453
[No Abstract] [Full Text] [Related]
14. Routine Molecular Profiling in Both Resectable and Unresectable pancreatic Adenocarcinoma: Relevance of Cytologic Samples.
Redegalli M; Grassini G; Magliacane G; Pecciarini L; Schiavo Lena M; Smart CE; Johnston RL; Waddell N; Maestro R; Macchini M; Orsi G; Petrone MC; Rossi G; Balzano G; Falconi M; Arcidiacono PG; Reni M; Doglioni C; Cangi MG
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2825-2833. PubMed ID: 36280101
[TBL] [Abstract] [Full Text] [Related]
15. Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of pancreatic Cysts.
Paniccia A; Polanco PM; Boone BA; Wald AI; McGrath K; Brand RE; Khalid A; Kubiliun N; O'Broin-Lennon AM; Park WG; Klapman J; Tharian B; Inamdar S; Fasanella K; Nasr J; Chennat J; Das R; DeWitt J; Easler JJ; Bick B; Singh H; Fairley KJ; Sarkaria S; Sawas T; Skef W; Slivka A; Tavakkoli A; Thakkar S; Kim V; Vanderveldt HD; Richardson A; Wallace MB; Brahmbhatt B; Engels M; Gabbert C; Dugum M; El-Dika S; Bhat Y; Ramrakhiani S; Bakis G; Rolshud D; Millspaugh G; Tielleman T; Schmidt C; Mansour J; Marsh W; Ongchin M; Centeno B; Monaco SE; Ohori NP; Lajara S; Thompson ED; Hruban RH; Bell PD; Smith K; Permuth JB; Vandenbussche C; Ernst W; Grupillo M; Kaya C; Hogg M; He J; Wolfgang CL; Lee KK; Zeh H; Zureikat A; Nikiforova MN; Singhi AD
Gastroenterology; 2023 Jan; 164(1):117-133.e7. PubMed ID: 36209796
[TBL] [Abstract] [Full Text] [Related]
16. Clinico-genomic Characterization of ATM and HRD in Pancreas cancer: Application for Practice.
Park W; O'Connor CA; Bandlamudi C; Forman D; Chou JF; Umeda S; Reyngold M; Varghese AM; Keane F; Balogun F; Yu KH; Kelsen DP; Crane C; Capanu M; Iacobuzio-Donahue C; O'Reilly EM
Clin Cancer Res; 2022 Nov; 28(21):4782-4792. PubMed ID: 36040493
[TBL] [Abstract] [Full Text] [Related]
17. Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer.
Visser IJ; Levink IJM; Peppelenbosch MP; Fuhler GM; Bruno MJ; Cahen DL
Pancreatology; 2022 Nov; 22(7):973-986. PubMed ID: 35864067
[TBL] [Abstract] [Full Text] [Related]
18. Molecular features of pancreaticobiliary neoplasms: Implications for diagnosis, prognostication, and therapy selection.
Layfield LJ; Zhang T; Esebua M
Diagn Cytopathol; 2023 Jan; 51(1):5-11. PubMed ID: 35751521
[TBL] [Abstract] [Full Text] [Related]
19. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer.
Sivapalan L; Thorn GJ; Gadaleta E; Kocher HM; Ross-Adams H; Chelala C
BMC Cancer; 2022 Apr; 22(1):369. PubMed ID: 35392854
[TBL] [Abstract] [Full Text] [Related]
20. Short report - Lethal and aggressive pancreatic cancer: molecular pathogenesis, cellular heterogeneity, and biomarkers of pancreatic ductal adenocarcinoma.
Kannan S; Shaik Syed Ali P; Sheeza A
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1017-1019. PubMed ID: 35179767
[TBL] [Abstract] [Full Text] [Related]
[Next]
